Suppr超能文献

脑心通胶囊改变高脂饮食喂养大鼠的肠道微生物群并预防高脂血症。

Naoxintong Capsule Alternates Gut Microbiota and Prevents Hyperlipidemia in High-Fat-Diet Fed Rats.

作者信息

Lu Yihang, Wan Haofang, Wu Yujia, Yang Jiehong, Yu Li, He Yu, Wan Haitong, Li Chang

机构信息

Key Laboratory of TCM Encephalopathy of Zhejiang Province, Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

Front Pharmacol. 2022 Mar 21;13:843409. doi: 10.3389/fphar.2022.843409. eCollection 2022.

Abstract

Naoxintong Capsule (NXT) is a formulated Traditional Chinese Medicine (TCM) widely applied in the treatment of cardiovascular and metabolic diseases, most of which are closely related to hyperlipidemia as a major risk factor. Given the current limited understandings to the role of gut microbiota in the lipid-lowering effect of NXT and other TCM products, this study investigated the regulation of gut microbiota and lipid metabolism by NXT, and their potential relationship. The chemical components of NXT were firstly analyzed with HPLC-MS method. In high fat diet (HFD)-fed rat models, as well as normal rats as control, the histopathological and biochemical changes of serum and liver were examined, including total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C). In addition, the gut microbiota community was analyzed using 16S rRNA sequencing technique, the fecal levels of gut microbiota related metabolites, including bile acids (BAs) and short chain fatty acids (SCFAs) were determined with HPLC-MS. The correlations of the clinical indicators and gut microbiota related indicators were then investigated statistically. The results showed that NXT exerted potential preventive effect on hyperlipidemia. Specifically, NXT significantly reduced the body weight, TC, TG and LDL-C in serum, increased HDL-C in serum, reduced the TC and TG in liver, as well as protected liver. The body weight, serum lipid levels and liver function were all significantly alleviated. The gut microbiota of the HFD-fed rats was reconstituted with supplementation of NXT. The fecal levels of gut microbiota related metabolites, including BAs and SCFAs were also altered. The correlation between the gut microbiota and clinical/metabolomic parameters was then studied. As the result, the amount of propionic aicd, / ratio (F/B) and the relative abundance of in feces are the most possibly potential therapeutic biomarkers of NXT. NXT was effective in regulation of gut microbiota and prevention of hyperlipidemia in HFD fed rats. The present work might provide novel insights into the anti-hyperlipidemia effect of TCM and afford new scientific evidence for clinical application of TCM.

摘要

脑心通胶囊(NXT)是一种配方中药,广泛应用于心血管和代谢疾病的治疗,其中大多数疾病与作为主要危险因素的高脂血症密切相关。鉴于目前对肠道微生物群在NXT和其他中药产品降脂作用中的作用了解有限,本研究调查了NXT对肠道微生物群和脂质代谢的调节作用及其潜在关系。首先采用高效液相色谱-质谱联用(HPLC-MS)法分析NXT的化学成分。在高脂饮食(HFD)喂养的大鼠模型以及作为对照的正常大鼠中,检测血清和肝脏的组织病理学和生化变化,包括总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)。此外,使用16S rRNA测序技术分析肠道微生物群群落,用HPLC-MS测定粪便中与肠道微生物群相关代谢物的水平,包括胆汁酸(BAs)和短链脂肪酸(SCFAs)。然后对临床指标与肠道微生物群相关指标的相关性进行统计学研究。结果表明,NXT对高脂血症具有潜在的预防作用。具体而言,NXT显著降低血清中的体重、TC、TG和LDL-C,增加血清中的HDL-C,降低肝脏中的TC和TG,并保护肝脏。体重、血脂水平和肝功能均得到显著改善。补充NXT可重塑HFD喂养大鼠的肠道微生物群。粪便中与肠道微生物群相关代谢物的水平,包括BAs和SCFAs也发生了改变。随后研究了肠道微生物群与临床/代谢组学参数之间的相关性。结果显示,粪便中丙酸的含量、/比值(F/B)和的相对丰度最有可能是NXT潜在的治疗生物标志物。NXT对HFD喂养大鼠的肠道微生物群具有调节作用,并能预防高脂血症。本研究可能为中药的抗高脂血症作用提供新的见解,并为中药的临床应用提供新的科学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2216/8978017/534e2d4029d8/fphar-13-843409-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验